Bausch Health Companies Inc.
BHCNYSECIK 885590HealthcareFiscal year ends Dec 31
Reports and events: 538 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-3020:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000885590-26-000107 |
| 2026-07-2920:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000105 |
| 2026-07-0120:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885590-26-000089 |
| 2026-05-1920:18 ET | 8-K | 5.07 Shareholder vote results | 0000885590-26-000057 |
| 2026-04-3022:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000885590-26-000053 |
| 2026-04-2920:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000051 |
| 2026-04-0820:05 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001140361-26-013816 |
| 2026-03-0222:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-085755 |
| 2026-02-1923:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000885590-26-000023 |
| 2026-02-1821:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-26-000020 |
| 2026-01-2321:06 ET | 8-K | 7.01 Regulation FD disclosure | 0000885590-26-000008 |
| 2026-01-1312:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000885590-26-000005 |
| 2026-01-0221:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-000052 |
| 2025-12-2912:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885590-25-000059 |
| 2025-12-2322:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000057 |
| 2025-12-1222:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-016089 |
| 2025-12-0900:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000054 |
| 2025-11-2412:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-291998 |
| 2025-10-3022:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000885590-25-000051 |
| 2025-10-2920:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000048 |
| 2025-10-0911:02 ET | 8-K | 5.07 Shareholder vote results | 0000885590-25-000044 |
| 2025-09-1113:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-200869 |
| 2025-08-2720:26 ET | DEF 14A | Proxy statementPeriod 2025-10-07 | 0001140361-25-032962 |
| 2025-08-1519:18 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-181736 |
| 2025-08-1513:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001539497-25-002158 |
| 2025-08-1401:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013594-25-001066 |
| 2025-07-3122:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000885590-25-000032 |
| 2025-07-3020:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000030 |
| 2025-07-2911:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-167131 |
| 2025-07-2412:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-163860 |
| 2025-07-1020:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157612 |
| 2025-06-2711:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-149731 |
| 2025-06-1820:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007605 |
| 2025-06-1720:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013594-25-000763 |
| 2025-06-1013:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007190 |
| 2025-05-2123:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013594-25-000695 |
| 2025-05-2120:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001539497-25-001480 |
| 2025-05-2100:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-123366 |
| 2025-05-1520:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-120802 |
| 2025-05-1420:20 ET | 8-K | 5.07 Shareholder vote results | 0000885590-25-000022 |
| 2025-05-0122:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000885590-25-000020 |
| 2025-04-3020:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000018 |
| 2025-04-1511:38 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-080728 |
| 2025-04-0921:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-075911 |
| 2025-04-0721:19 ET | SCHEDULE 13D | Ownership report, active investor | 0000902664-25-001705 |
| 2025-04-0220:05 ET | DEF 14A | Proxy statementPeriod 2025-05-13 | 0001140361-25-011851 |
| 2025-03-2518:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000013 |
| 2025-03-1915:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885590-25-000010 |
| 2025-02-2000:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000885590-25-000007 |
| 2025-02-1921:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000885590-25-000004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.